Kyverna Therapeutics, Inc.

NasdaqGS:KYTX Stock Report

Market Cap: US$166.6m

Kyverna Therapeutics Management

Management criteria checks 0/4

We currently do not have sufficient information about the CEO.

Key information

Warner Biddle

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.2yrs
Board average tenure2.4yrs

Recent management updates

Recent updates

Kyverna Therapeutics: CAR T-Cells Trying To Impact Inflammatory Disorders

Dec 12

Here's Why We're Watching Kyverna Therapeutics' (NASDAQ:KYTX) Cash Burn Situation

Nov 17
Here's Why We're Watching Kyverna Therapeutics' (NASDAQ:KYTX) Cash Burn Situation

We're Not Very Worried About Kyverna Therapeutics' (NASDAQ:KYTX) Cash Burn Rate

Aug 08
We're Not Very Worried About Kyverna Therapeutics' (NASDAQ:KYTX) Cash Burn Rate

CEO

Warner Biddle

less than a year

Tenure

Mr. Warner Biddle serves as CEO & Director of Kyverna Therapeutics, Inc. since September 16, 2024. He is Ad Interim Head of Kite at Kite Pharma, Inc. from 2023. He is Global Head of Commercial of Kite Phar...

Leadership Team

NamePositionTenureCompensationOwnership
Karen Walker
Chief Technology Officer3.3yrsUS$1.08m0.022%
$ 37.2k
Warner Biddle
CEO & Directorless than a yearno datano data
Ryan Jones
Chief Financial Officer2yrsno data0.10%
$ 169.6k
Tom Van Blarcom
Senior VP & Head of Research2.4yrsno datano data
Tracy Rossin
Senior Vice President of Corporate Affairs & Communications and Investor Relationsless than a yearno datano data
Cara Bauer
Chief Human Resources Officerless than a yearno datano data
Dominic Borie
President of Research & Development2.3yrsno data1.04%
$ 1.7m
Devin Murray
Senior Vice President of Partnerships & Alliancesno datano datano data
Dan Maziasz
Chief Business Officerless than a yearno datano data

1.2yrs

Average Tenure

54.5yo

Average Age

Experienced Management: KYTX's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Warner Biddle
CEO & Directorless than a yearno datano data
Daniel Spiegelman
Independent Director3.8yrsUS$245.05k0%
$ 0
Fred Cohen
Independent Director6.3yrsUS$155.05k0%
$ 0
Beth Seidenberg
Independent Director6.3yrsUS$155.05k0%
$ 0
Ian T. Clark
Independent Chairman3.3yrsUS$306.74k0%
$ 0
Christi Shaw
Directorless than a yearno datano data
Georg Schett
Member of Scientific Advisory Board2.4yrsno datano data
Mert Aktar
Directorless than a yearno datano data
Ignacio Sanz
Member of Scientific Advisory Board3.8yrsno datano data
Peter Merkel
Member of Scientific Advisory Board2.4yrsno datano data
Steve Liapis
Independent Director2.2yrsno datano data

2.4yrs

Average Tenure

64yo

Average Age

Experienced Board: KYTX's board of directors are not considered experienced ( 2.4 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/08 18:05
End of Day Share Price 2025/01/08 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kyverna Therapeutics, Inc. is covered by 5 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mitchell KapoorH.C. Wainwright & Co.
Lut Ming ChengJ.P. Morgan
Thomas SmithLeerink Partners LLC